Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

HSR Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Blood Pressure, Readmission, and Mortality Among Patients Hospitalized With Acute Kidney Injury.

Griffin BR, Vaughan-Sarrazin M, Shi Q, Ten Eyck P, Reisinger HS, Kennelty K, Good MK, Swee ML, Yamada M, Lund BC, Jalal DI. Blood Pressure, Readmission, and Mortality Among Patients Hospitalized With Acute Kidney Injury. JAMA Network Open. 2024 May 1; 7(5):e2410824.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
   Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions



Abstract:

IMPORTANCE: Acute kidney injury (AKI) complicates 20% to 25% of hospital admissions and is associated with long-term mortality, especially from cardiovascular disease. Lower systolic blood pressure (SBP) following AKI may be associated with lower mortality, but potentially at the cost of higher short-term complications. OBJECTIVE: To determine associations of SBP with mortality and hospital readmissions following AKI, and to determine whether time from discharge affects these associations. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study of adults with AKI during a hospitalization in Veteran Healthcare Association (VHA) hospitals was conducted between January 2013 and December 2018. Patients with 1 year or less of data within the VA system prior to admission, severe or end-stage liver disease, stage 4 or 5 chronic kidney disease, end-stage kidney disease, metastatic cancer, and no blood pressure values within 30 days of discharge were excluded. Data analysis was conducted from May 2022 to February 2024. EXPOSURE: SBP was treated as time-dependent (categorized as < 120 mm Hg, 120-129 mm Hg, 130-139 mm Hg, 140-149 mm Hg, 150-159 mm Hg, and = 160 mm Hg [comparator]). Time spent in each SBP category was accumulated over time and represented in 30-day increments. MAIN OUTCOMES AND MEASURES: Primary outcomes were time to mortality and time to all-cause hospital readmission. Cox proportional hazards regression was adjusted for demographics, comorbidities, and laboratory values. To evaluate associations over time, hazard ratios (HRs) were calculated at 60 days, 90 days, 120 days, 180 days, 270 days, and 365 days from discharge. RESULTS: Of 237?409 admissions with AKI, 80?960 (57?242 aged 65 years or older [70.7%]; 77?965 male [96.3%] and 2995 female [3.7%]) were included. The cohort had high rates of diabetes (16?060 patients [20.0%]), congestive heart failure (22?516 patients [28.1%]), and chronic lung disease (27?682 patients [34.2%]), and 1-year mortality was 15.9% (12?876 patients). Overall, patients with SBP between 130 and 139 mm Hg had the most favorable risk level for mortality and readmission. There were clear, time-dependent mediations on associations in all groups. Compared with patients with SBP of 160 mm Hg or greater, the risk of mortality for patients with SBP between 130 and 139 mm Hg decreased between 60 days (adjusted HR, 1.20; 99% CI, 1.00-1.44) and 365 days (adjusted HR, 0.58; 99% CI, 0.45-0.76). SBP less than 120 mm Hg was associated with increased risk of mortality at all time points. CONCLUSIONS AND RELEVANCE: In this retrospective cohort study of post-AKI patients, there were important time-dependent mediations of the association of blood pressure with mortality and readmission. These findings may inform timing of post-AKI blood pressure treatment.





Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.